Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham
Dr. Marrazzo is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health and in the setting of HIV. She is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America (IDSA), and was elected to the IDSA Board of Directors in 2018. She was Chair of the American Board of Internal Medicine Council from 2015-2018. Dr. Marrazzo conducts research on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception, and its relationship to women’s risk of STI/HIV acquisition. She was the Protocol Co-Chair for the VOICE Study (MTN-003), a placebo-controlled trial that randomized over 5,000 women in South Africa, Uganda, and Zimbabwe to oral or vaginal tenofovir-based HIV pre-exposure prophylaxis. She chairs the Biomedical Science Committee of the HIV Prevention Trial Network, the group tasked with integrating the biomedical science agenda across numerous clinical trials of antiretroviral prevention agents. She is also the Principal Investigator of the NIH-funded STI Clinical Trials Group and Co-PI of the Leadership Group of the Vaccine Treatment and Evaluation Unit.